These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10999793)

  • 1. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.
    von Eckardstein A; Schulte H; Assmann G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3101-8. PubMed ID: 10999793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
    Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting plasma glucose cutoff value for the prediction of future diabetes development: a study of middle-aged Koreans in a health promotion center.
    Kim DJ; Cho NH; Noh JH; Kim HJ; Choi YH; Jung JH; Min YK; Lee MS; Lee MK; Kim KW
    J Korean Med Sci; 2005 Aug; 20(4):562-5. PubMed ID: 16100444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.
    Sayeed MA; Mahtab H; Khanam PA; Keramat Ali SM; Chowdhury RI; Vaaler S; Hussain A; Azad Khan AK
    Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):105-14. PubMed ID: 16240981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe.
    Lancet; 1999 Aug; 354(9179):617-21. PubMed ID: 10466661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose.
    Lankarani KB; Eshraghian A; Nikeghbalian S; Janghorban P; Malek-Hosseini SA
    Exp Clin Transplant; 2014 Feb; 12(1):46-51. PubMed ID: 23902591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study.
    Bozorgmanesh M; Hadaegh F; Saadat N; Azizi F
    Acta Diabetol; 2012 Oct; 49(5):341-8. PubMed ID: 21617883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal fasting plasma glucose levels and type 2 diabetes in young men.
    Tirosh A; Shai I; Tekes-Manova D; Israeli E; Pereg D; Shochat T; Kochba I; Rudich A;
    N Engl J Med; 2005 Oct; 353(14):1454-62. PubMed ID: 16207847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in glucose tolerance among elderly Finnish men during a five-year follow-up: the Finnish cohorts of the Seven Countries Study.
    Stengård JH; Pekkanen J; Tuomilehto J; Kivinen P; Kaarsalo E; Tamminen M; Nissinen A; Karvonen MJ
    Diabete Metab; 1993; 19(1 Pt 2):121-9. PubMed ID: 8314414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
    Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
    J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
    Harati H; Hadaegh F; Tohidi M; Azizi F
    Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Impaired Fasting Glucose with Hypertension.
    Gul N; Parveen A; Zaka N; Rafique M
    J Coll Physicians Surg Pak; 2018 Oct; 28(10):748-752. PubMed ID: 30266117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD.
    Xu L; Jiang CQ; Lam TH; Cheng KK; Yue XJ; Lin JM; Zhang WS; Thomas GN
    Metabolism; 2010 Mar; 59(3):367-72. PubMed ID: 19828159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.